Schiltigheim, France

Yves Larmet

This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves Larmet. Retrieved from https://idiyas.com/inventor/yves-larmet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yves Larmet: Innovator in Epilepsy Treatment

Introduction

Yves Larmet is a notable inventor based in Schiltigheim, France. He has made significant contributions to the field of medical science, particularly in the treatment of epilepsy. His innovative approach has garnered attention in the medical community.

Latest Patents

Yves Larmet holds a patent for a method of treating epilepsy. This method involves the therapeutic use of brain-derived neurotrophic factor (BDNF) to address the condition. His work in this area is crucial for advancing treatment options for patients suffering from epilepsy.

Career Highlights

Larmet is associated with Amgen Inc., a leading biotechnology company. His role at Amgen has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. He has a total of 1 patent to his name, reflecting his innovative spirit and dedication to improving healthcare.

Collaborations

Yves Larmet has worked alongside notable colleagues such as Josette Francedillaoise Carnahan and Antoine Depaulis. Their combined expertise has fostered a collaborative environment that enhances the development of new therapeutic methods.

Conclusion

Yves Larmet's contributions to epilepsy treatment through his innovative patent highlight his commitment to advancing medical science. His work continues to inspire future research and development in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…